Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M29.5Revenue (TTM) $M12.9Net Margin (%)-292.4Altman Z-Score-4.9
Enterprise Value $M24.8EPS (TTM) $-9.1Operating Margin %-69.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-292.4Higher ROA y-yN
Price/Book0.810-y EBITDA Growth Rate %-8.8Quick Ratio2.2Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %14.1Current Ratio3.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-111.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M9.8ROIC % (ttm)-30.7Gross Margin Increase y-yY

Gurus Latest Trades with KOOL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KOOLKen Fisher 2011-09-30 Sold Out -0.0001%$24 - $42.6
($34.42)
$ 3.03-91%Sold Out0
KOOLKen Fisher 2011-06-30 Buy $38.2 - $49.4
($43.87)
$ 3.03-93%New holding1,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KOOL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


KOOL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boyalife (Hong Kong) Ltd10% Owner 2016-12-26Buy6,102,942$2.5220.24view
Harris KennethFormer Director/Officer 2015-11-10Sell4,043$12-74.75view
Harris KennethFormer Director/Officer 2015-11-03Sell526$12-74.75view
Harris KennethFormer Director/Officer 2015-10-29Sell432$12-74.75view
Plavan Matthew TFormer CEO 2015-09-02Sell864$13.6-77.72view
Rhein Denis MichaelDirector 2014-12-01Sell0$0-77.72view
ENGLE J MELVILLEChairman & CEO 2011-03-10Buy1,125$46-93.41view
ARTILES JORGEVP, Quality/Regulatory Affairs 2010-01-13Buy5$48.8-93.79view
ENGLE J MELVILLECEO 2009-09-25Buy1,250$45.6-93.36view
MCENANY PATRICK JDirector 2009-05-19Buy313$46.4-93.47view

Quarterly/Annual Reports about KOOL:

News about KOOL:

Articles On GuruFocus.com
Insiders Roundup: Vera Bradley Tops List Dec 30 2016 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 11 2011 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 04 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 04 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 09 2009 
THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares Sep 28 2009 
THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares May 12 2009 
THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2009 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 05 2009 

More From Other Websites
CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jan 17 2017
Cesca Therapeutics Appoints Dr. Joseph Thomis to Its Board of Directors Jan 17 2017
CESCA ANNOUNCES FDA APPROVAL OF IDE SUPPLEMENT FOR PHASE III CLINICAL TRIAL Jan 05 2017
Cesca Announces FDA Approval of IDE Supplement for Phase III Clinical Trial Jan 05 2017
CESCA THERAPEUTICS TO PRESENT AT THE 9TH ANNUAL BIOTECH SHOWCASE Jan 03 2017
Cesca Therapeutics to Present at the 9th Annual Biotech Showcase Jan 03 2017
Insiders Keep Buying as Market Wraps on 2016: Tronic, Six Flags, Virtu Financial, Cesca Therapeutics... Jan 01 2017
Nvidia (NVDA) Can’t Shake Citron, Cempra (CEMP) Slammed by FDA Rejection, Plus 3 Other Major... Dec 29 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Dec 20 2016
Cesca Submits IDE Supplement for CLI Pivotal Trial Dec 05 2016
Cesca Therapeutics to Present at the 9th Annual LD Micro Main Event Dec 02 2016
CESCA THERAPEUTICS INC. Financials Nov 24 2016
Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q1, 2017 By the Numbers : November 23, 2016 Nov 23 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Financial Statements and Exhibits Nov 22 2016
Cesca Therapeutics Reports First Quarter Fiscal 2017 Results and Provides Business Update Nov 17 2016
Q1 2017 Cesca Therapeutics Inc Earnings Release - After Market Close Nov 17 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K/A, Triggering Events That Accelerate or Increase a Direct... Nov 17 2016
Cesca Therapeutics to Announce First Quarter Fiscal 2017 Results on November 17, 2016 Nov 16 2016
Arcadia Biosciences Announces Third-Quarter 2016 Financial Results and Business Highlights Nov 10 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers Nov 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)